These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11828884)

  • 1. Protein "AGEing"--cytotoxicity of a glycated protein increases with its degree of AGE-modification.
    Gasic-Milenkovic J; Loske C; Deuther-Conrad W; Münch G
    Z Gerontol Geriatr; 2001 Dec; 34(6):457-60. PubMed ID: 11828884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress.
    Loske C; Neumann A; Cunningham AM; Nichol K; Schinzel R; Riederer P; Münch G
    J Neural Transm (Vienna); 1998; 105(8-9):1005-15. PubMed ID: 9869332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism.
    Deuther-Conrad W; Loske C; Schinzel R; Dringen R; Riederer P; Münch G
    Neurosci Lett; 2001 Oct; 312(1):29-32. PubMed ID: 11578838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells.
    Wei Y; Chen L; Chen J; Ge L; He RQ
    BMC Cell Biol; 2009 Feb; 10():10. PubMed ID: 19216769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
    Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
    Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins.
    Deuther-Conrad W; Franke S; Sommer M; Henle T; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S63-6. PubMed ID: 11168985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells.
    Park CH; Kim JW
    Korean J Ophthalmol; 2012 Apr; 26(2):123-31. PubMed ID: 22511839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.
    Pastino AK; Greco TM; Mathias RA; Cristea IM; Schwarzbauer JE
    Matrix Biol; 2017 May; 59():39-53. PubMed ID: 27425255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.
    Wong A; Lüth HJ; Deuther-Conrad W; Dukic-Stefanovic S; Gasic-Milenkovic J; Arendt T; Münch G
    Brain Res; 2001 Nov; 920(1-2):32-40. PubMed ID: 11716809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitization of DNA damage by glycated proteins.
    Wondrak GT; Jacobson EL; Jacobson MK
    Photochem Photobiol Sci; 2002 May; 1(5):355-63. PubMed ID: 12653475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development.
    McCarthy AD; Etcheverry SB; Cortizo AM
    Acta Diabetol; 2001; 38(3):113-22. PubMed ID: 11827431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
    Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
    J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
    Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
    Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation endproducts in ageing and Alzheimer's disease.
    Münch G; Thome J; Foley P; Schinzel R; Riederer P
    Brain Res Brain Res Rev; 1997 Feb; 23(1-2):134-43. PubMed ID: 9063589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
    Yan SD; Chen X; Schmidt AM; Brett J; Godman G; Zou YS; Scott CW; Caputo C; Frappier T; Smith MA
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7787-91. PubMed ID: 8052661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel advanced glycation end product derived from lactaldehyde.
    Fujimoto S; Murakami Y; Miyake H; Hayase F; Watanabe H
    Biosci Biotechnol Biochem; 2019 Jun; 83(6):1136-1145. PubMed ID: 30822216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.